🔎 Trials Near Me

Akèy › Depresyon › Ohio

Etid klinik pou Depresyon nan Ohio

26 etid pou Depresyon ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Independence
  • Seaport Investigator Site, North Canton
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Insight Clinical Trials, Independence
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Columbus
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Mason
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06911112

E-Mindfulness Approaches for Living After Breast Cancer

  • Indu and Raj Soin Medical Center, Beavercreek
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Ohio State University Comprehensive Cancer Center, Columbus
  • ak 16 plis
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

  • Lindner Center of Hope, Mason
Ap rekriteFaz 1/2
Laj 18 a 60 · Tout sèks · Mizajou Aug 3, 2026 · NCT06795451

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Neuro-Behavioral Clinical Research, North Canton
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Developing Resilience and Anxiety Management Through the Arts

  • Case Western Reserve University, Cleveland
Ap rekrite
Laj 8 a 17 · Tout sèks · Mizajou Jul 31, 2026 · NCT07033052

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

  • Cleveland Clinic - Cleveland /ID# 276309, Cleveland
  • CincyScience /ID# 226318, West Chester
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Jul 27, 2026 · NCT04777357

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Avon Lake
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

  • The Ohio State University Department of Psychiatry, Columbus
Ap rekriteFaz 2
Laj 21 a 65 · Tout sèks · Mizajou Jul 23, 2026 · NCT06820723

Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety

  • Ohio State University Wexner Medical Center, Columbus
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT07717541

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteEtid obsèvasyon
18 Months – 11 Years · Tout sèks · Mizajou Jul 6, 2026 · NCT07048574

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • The Ohio State University, Columbus
  • Charak Center for Health and Wellness, Garfield Heights
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715

Teenthrive 2: Treatments for Improving Mood in Teens

  • Nationwide Children's Hospital, Columbus
Ap rekrite
Laj 12 a 18 · Tout sèks · Mizajou Jun 10, 2026 · NCT07475845

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT07216404

A Precision Medicine Approach to Target Engagement for Emotion Regulation

  • Ohio State University, Columbus
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT05651295

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • The Ohio State University, Columbus
  • Neuro Behavioral Clinical Research, Inc., North Canton
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Virtual Patient Groups for Sarcoidosis Associated Fatigue

  • Cleveland Clinic, Cleveland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2026 · NCT07073963

Positive Processes and Transition to Health - Single-Session (PATH-SS)

  • Case Western Reserve University, Cleveland
Ap rekriteMande peman pou patisipan yo
Laj 18 a 65 · Tout sèks · Mizajou Apr 22, 2026 · NCT06900712

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

  • University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati
Ap rekriteFaz 3
Laj 15 a 24 · Tout sèks · Mizajou Mar 11, 2026 · NCT07464886

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekrite
Laj 12 a 22 · Tout sèks · Mizajou Oct 30, 2025 · NCT06232304

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Avon Lake
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

Mechanisms of Rumination Change in Adolescent Depression

  • Nationwide Children's Hospital, Columbus
  • The Ohio State University, Columbus
Ap rekrite
Laj 14 a 17 · Tout sèks · Mizajou Aug 11, 2025 · NCT03859297

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  • Clinical Research Site, Cincinnati
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.